Skip to main content

Advertisement

Log in

Co-mutated CALR and MPL driver genes in a patient with myeloproliferative neoplasm

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Levine RL, Wadleigh M, Cools J et al (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7(4):387–397

    Article  CAS  PubMed  Google Scholar 

  2. Klampfl T, Gisslinger H, Harutyunyan AS et al (2013) Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 369(25):2379–2390. doi:10.1056/NEJMoa1311347

    Article  CAS  PubMed  Google Scholar 

  3. Pikman Y, Lee BH, Mercher T et al (2006) MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med 3(7):e270

    Article  PubMed  PubMed Central  Google Scholar 

  4. Kralovics R, Passamonti F, Buser AS et al (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352(17):1779–1790

    Article  CAS  PubMed  Google Scholar 

  5. Defour JP, Chachoua I, Pecquet C et al (2016) Oncogenic activation of MPL/thrombopoietin receptor by 17 mutations at W515: implications for myeloproliferative neoplasms. Leukemia 30:1214–1216

    CAS  PubMed  Google Scholar 

  6. Chachoua I, Pecquet C, El-Khoury M et al (2016) Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants. Blood 127:1325–1335

    Article  CAS  PubMed  Google Scholar 

  7. Nangalia J, Massie CE, Baxter EJ et al (2013) Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 369(25):2391–2405

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Tefferi A, Pardanani A (2014) Genetics: CALR mutations and a new diagnostic algorithm for MPN. Nat Rev Clin Oncol 11(3):125–126. doi:10.1038/nrclinonc.2014.16

    Article  CAS  PubMed  Google Scholar 

  9. Tefferi A, Lasho TL, Finke CM et al (2014) CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons. Leukemia 28(7):1472–1477. doi:10.1038/leu.2014.3

    Article  CAS  PubMed  Google Scholar 

  10. Usseglio F, Beaufils N, Calleja A et al (2017) Detection of CALR and MPL mutations in low allelic burden JAK2 V617F essential thrombocythemia. J Mol Diagn 19(1):92–98. doi:10.1016/j.jmoldx.2016.08.006

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors like to thank Victoria Calvo for her technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mónica Bernal.

Ethics declarations

Informed consent

Informed consent was obtained from the patient for being included in the study.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bernal, M., Jiménez, P., Puerta, J. et al. Co-mutated CALR and MPL driver genes in a patient with myeloproliferative neoplasm. Ann Hematol 96, 1399–1401 (2017). https://doi.org/10.1007/s00277-017-3023-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-017-3023-9

Keywords

Navigation